Defensins are small (30 -45 amino acid residues) cationic proteins with broad antimicrobial activity against many bacteria and fungi, some enveloped viruses, and other activities such as chemoattraction of a range of different cell types to the sites of inflammation. These proteins represent attractive targets for developing novel antimicrobial agents and modulators of immune responses with therapeutic applicability. In this report, we present the results of functional and structural studies of 26 single-site mutants of human -defensin 1 (hBD1). All mutants were assayed for antimicrobial activity against Escherichia coli (ATCC strain 25922) and for chemotactic activity with CCR6-transfected HEK293 cells. To analyze the structural implications of mutagenesis and to verify the correctness of the disulfide connectivity, we used x-ray crystallography to conduct complete structural studies for 10 mutants in which the topology of disulfides was the same as in the native hBD1. Mutations did not induce significant changes of the tertiary structure, suggesting that the observed alterations of biological properties of the mutants were solely associated with changes in the respective side chains. We found that cationic residues located near the C terminus (Arg Defensins are recognized as an important element of the human innate immune system (1-4). The defensin family is composed of small (3-5 kDa), cationic, and cysteine-rich proteins. In human defensins, the connectivity of three disulfide bridges forms the basis for assigning them into one of two classes, the ␣-and -defensins (5-7). In -defensins, the topology of the three disulfide bridges is 1-5, 2-4, and 3-6, meaning that the first cysteine in the sequence is covalently linked to the fifth, and so on. Three human -defensins, hBD1-3, 4 have been isolated from natural sources and characterized in detail (8 -11). Additionally, the recombinant or synthetic preparations of hBD4, hBD27, and hBD28 have also been described and characterized functionally (12, 13). Analysis of the human genome indicates the existence of over 40 potential coding regions for these peptides (14,15).In addition to broad antimicrobial activity, hBDs have also been recognized as modulators of cell-mediated adaptive immunity, due to their chemotactic and immunoenhancing activity (16 -19). Recent studies revealed that -defensins also play a role in cell differentiation, tissue remodeling, and sperm maturation (20 -22).The first human -defensin to be discovered, hBD1, is constitutively expressed in the epithelial cells of the urinary and respiratory tracts and in keratinocytes of skin (9,23,24). A naturally occurring 36-amino acid hBD1 peptide shows anti-bacterial activity at micromolar concentrations against some Gramnegative bacteria (i.e. Escherichia coli, Pseudomonas aeruginosa, and Klebsiella pneumoniae), as well as yeast Candida albicans. When tested in vitro, hBD1 is relatively less potent against the Gram-positive Streptococcus aureus (9, 10, 23).HBD1 and hBD2 selectively chemoattract hum...